Pay in 4 interest-free payments of $5.94 Learn more
Ships within 48 hours · Estimated delivery Aug 15 - Aug 20
Proposed Mechanism BPC-157 appears to work through multiple pathways: Maintaining vesicular integrity (affecting VMATs and dopamine transporters) Possibly occupying its own vesicular storage sites Competing for dopamine receptor binding Functionally substituting when dopaminergic neurons are lost This last property, essentially filling in for missing dopamine function, would explain why the peptide counteracts both receptor agonists (apomorphine) and antagonists (haloperidol, fluphenazine, clozapine, sulpiride) with equal effectiveness
Analytical verification using high performance liquid chromatography (HPLC) and mass spectrometry (MS) is essential to confirm the purity and identity of BPC-157, ensuring that research compounds meet rigorous quality standards
2000;113 Pt 24(24):4435-4440
A.SemenykhinaO
BPC-157 does promote blood vessel formation through VEGF pathways, which has raised theoretical concerns about cancer growth
Unsupervised Use: These peptides should only be administered under medical guidance to ensure dosing accuracy and safety
